Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Neoplasms 3Leukemia, Myeloid, Acute 2Carcinoma, Non-Small-Cell Lung 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Leukemia, Biphenotypic, Acute 1Leukemia 1Carcinoma 1BRAF V600E Mutation 1Adenocarcinoma 1

Interventions

Carboplatin 784Pemetrexed 607Cisplatin 545Paclitaxel 491pembrolizumab 464Docetaxel 440Gemcitabine 328Erlotinib Hydrochloride 307Radiotherapy 258Nivolumab 244Bevacizumab 233osimertinib 178Drug Therapy 164durvalumab 157atezolizumab 135Gefitinib 134Radiosurgery 133Vinorelbine 111Cetuximab 97130-nm albumin-bound paclitaxel 94Ipilimumab 86Magnetic Resonance Spectroscopy 84Taxes 79Surgical Procedures, Operative 74Afatinib 68Albumin-Bound Paclitaxel 66Specimen Handling 61Etoposide 61Cyclophosphamide 60tislelizumab 59

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Cobicistat × Clear all
NCT05748093 2024-08-09

OSIBOOST 2

Maastricht University Medical Center

Phase 4 Recruiting
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03858491 2022-09-26

OSIBOOST

Academisch Ziekenhuis Maastricht

Phase EARLY_PHASE1 Completed
11 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡